These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 724647)

  • 21. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 23. The antigens and antibodies of hepatitis B: a review.
    Lee WM
    J S C Med Assoc; 1986 Oct; 82(10):613-9. PubMed ID: 3537522
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum markers of hepatitis B virus in chronic active hepatitis].
    Jirón MI; Armas-Merino R; Soto JR; Vargas-Tank L; Lobo G; Pacheco J; Wolff C
    Rev Med Chil; 1983 May; 111(5):463-5. PubMed ID: 6665359
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Occurrence of antigens and specific antibodies against hepatitis B virus infection in relation to other immunoserological indicators in alcohol-dependent persons].
    Boroń P; Bobrowska E; Borzuchowska A; Kaczmarska A; Kamińska H; Prokopowicz D; Szpakowicz T; Sidun Z
    Przegl Epidemiol; 1987; 41(3):311-8. PubMed ID: 3432569
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serological markers of hepatitis B virus in chronic hepatitis and cirrhosis].
    Rull S; Ruiz-Capellán R; Araiz J; Panizo A; Serrano M; Prieto-Valtueña J
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):321-5. PubMed ID: 4001527
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sero-epidemiologic study of markers for hepatitis B in dentists in Ille-et-Vilaine].
    Zourbas J; Le Hesran J
    Inf Dent; 1985 Oct; 67(36):3801-9. PubMed ID: 3867623
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B virus reactivation in a large haemodialysis unit: virological and infection control issues.
    Bhattacharya S; Ijaz S; Ratnaraja N; Smith S; Osman H; Boxall E
    J Clin Virol; 2009 Sep; 46(1):101-3. PubMed ID: 19560397
    [No Abstract]   [Full Text] [Related]  

  • 31. Outbreaks of hepatitis B virus infection among hemodialysis patients-- California, Nebraska, and Texas, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Apr; 45(14):285-9. PubMed ID: 8598825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of DNA polymerase and radioimmune assays for the detection of hepatitis B antigens and antibodies.
    Cappel R; Clinet G; Thiry L
    Dev Biol Stand; 1975; 30():186-92. PubMed ID: 1204957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency and prognostic value of the "e" system in hepatitis B virus infections].
    Onesciuc C; Onesciuc I; Jebeleanu L; Serban I; Gorgan V; Crîstina D; Oprean N; Feticu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(2):117-20. PubMed ID: 7423088
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus].
    Novak I; Kselikova M; Urbankova I
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 36. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 37. [Occult hepatitis B virus infection in patients treated with chronic hemodialysis].
    Teruel JL; Mateos ML; Fernández Lucas M; Ortuño J
    Nefrologia; 2005; 25(1):83-4. PubMed ID: 15789543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serological markers of hepatitis B in clinical practice].
    Juszczyk J; Kryska A; Bereszyńska I
    Pol Tyg Lek; 1987 Oct; 42(43):1351-4. PubMed ID: 3444768
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis B among dentists in the Kyobashi district].
    Shiyo; 1983 Nov; 31(11):38-42. PubMed ID: 6593520
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.